GlassScriptPhysician profile
Tara Hewitt
NPI 1780206235
$897.91
in general payments reported to CMS, 2019-2025
23 companies · $48.90 in 2025
The $48.90 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $195 · 2023: $115 · 2024: $370 · 2025: $48.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $132.72 | 2024 | Voquezna |
| Amgen INC. | $122.19 | 2022-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $96.74 | 2022-2024 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $94.40 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $54.82 | 2021-2024 | Xarelto |
| Organogenesis INC. | $48.90 | 2025 | Affinity |
| Novo Nordisk INC | $38.50 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.54 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.75 | 2021-2022 | |
| Insulet Corporation | $27.46 | 2021 | |
| Lundbeck LLC | $24.19 | 2024 | Rexulti |
| Daiichi Sankyo INC. | $23.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.43 | 2022 | |
| Lilly USA, LLC | $21.12 | 2023 | Mounjaro |
| Abbvie INC. | $19.70 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.46 | 2023 | Dificid, Zerbaxa, Recarbrio |
| Nabriva Therapeutics, Plc | $14.36 | 2022 | |
| Hologic Sales and Service, LLC | $13.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.89 | 2024 | Xifaxan |
| Exact Sciences Corporation | $13.43 | 2024 | Cologuard Collection Kit |
| Baxter Healthcare | $13.41 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $11.90 | 2022 | |
| Mylan Specialty L.P. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Hewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.